Hims & Hers Health, Inc. reported record Q3 '24 revenues of over $400 million, beating estimates by nearly $19 million, and ...
The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic version of liraglutide, an older GLP-1 weight loss drug, next year. The ...
Barron's on MSN57m
These Stocks Are Moving the Most Today: Palantir, DJT, Boeing, Lattice Semi, Astera Labs, Archer Daniels, Cirrus Logic, Super Micro, and MoreStocks were rising Tuesday as voters headed to the polls to elect the next U.S. president.These stocks were making moves ...
Investor's Business Daily on MSN40m
Apellis Pharmaceuticals Dives On Worse-Than-Expected Syfovre SalesApellis stock plunged Tuesday after third-quarter sales of the company's eye drug, Syfovre, widely missed Wall Street's expectations.
Cleveland-Cliffs (CLF) is falling after the steel company's third-quarter report, though call traders are chiming in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback